摘要
目的观察艾瑞昔布片治疗退行性膝关节炎的临床疗效。方法 108例退行性膝关节炎患者接受口服艾瑞昔布片治疗8周,通过视觉模拟评分法(VAS)和Lysholm膝关节评分,分析治疗前,治疗后第2、4、6、8周的疼痛程度和膝关节功能。结果随着治疗时间的延长,患者疼痛VAS评分逐渐降低,膝关节功能改善Lysholm膝关节评分逐渐升高,差异均有统计学意义(P<0.05)。结论艾瑞昔布片治疗退行性膝关节炎疗效确切,值得临床推广。
Objective To discuss the clinical efficacy and safety of imrecoxib tablets for curing the retrogressive knee arthritis.Methods 108 patients with retrogressive knee arthritis receive oral imrecoxib tablets treatment for 8 weeks.By the visual analogue scale( VAS) and the Lysholm knee grade,analysis level of pain and knee joint function before treatment and after treatment for 2,4,6,8 weeks.Results With the extension of treatment time,the pain VAS score of patients gradually reduce,knee joint function improve,the Lysholm knee grade gradually increase.the differences were statistically significant( P <0.05).Conclusion The clinical efficacy of Imrecoxib Tablets for curing the retrogressive knee arthritis is definite,is worthy of clinical promotion.
出处
《临床合理用药杂志》
2016年第16期38-39,共2页
Chinese Journal of Clinical Rational Drug Use
